• Sunday,September 22,2024
ururembotoursandtravel.com
X

Dysautonomia Intl. on X: Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well to the medication. Read

$ 15.99

4.6 (623) In stock

Share

New Department of Defense grant to study fragile x syndrome in human cells – Waisman Center – UW–Madison

Dysautonomia Intl. (@Dysautonomia) / X

ABC Cardiol

Dysautonomia International - The first of several journal articles detailing results from the Big POTS Survey is now available! The study was a combined effort between Dysautonomia International, Vanderbilt University and University

Solved When researchers are studying the effect of new drug

Neurocardiology: Dysautonomia, Orthostatic Intolerance, POTS & More - James Glenn MD

Solved A nurse is collecting data from a client who is

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia Intl. (@Dysautonomia) / X

American Dysautonomia Institute - POTS

Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection

Dysautonomia Intl. (@Dysautonomia) / X

Solved The Ruritanian Ministry of Health has discovered that

Dysautonomia Intl. (@Dysautonomia) / X